I studied law at the University of Fribourg, Switzerland, and at Stockholm University, Sweden, and was admitted to the Swiss bar as an attorney-at-law. I obtained my PhD in private law and capital market law from the  University of Zurich, Switzerland. I hold a postgraduate degree in EU Competition Law from King's College, London, UK. My early legal practice spanned Switzerland and the US.

From 2014 to 2022, I worked as Senior Legal Counsel at the  pharmaceutical company Roche in Basel, Switzerland, South San Francisco and New Jersey, US.  I led and advised on licensing, strategic collaboration and M&A transactions across multiple disease areas, including gene therapy, oncology, and data-driven and AI-based projects. I served as Vice-President of the Biodiversity Expert Committee and represented Roche in external expert bodies and industry associations, including  the European Federation of Pharmaceutical Industries and Associations.

Since 2022, I have been Scientific Director of the Centre for Life Sciences Law at the Faculty of Law of the University of Basel, Switzerland, and a senior legal researcher at the University of Basel. I teach and lecture at several Swiss universities, including ETH Zurich, and in executive education programmes. My research lies at the intersection of technology law, legal theory, contract law, intellectual property and competition law, with a particular focus on the regulation and governance of transformative biotechnologies, including CRISPR gene editing, as well as the legal dimensions of innovation, responsibility and access in global health contexts.

I am currently based at the Max Planck Institute for Legal History and Legal Theory in Frankfurt am Main, Germany.